Dalby, Amanda <br/><br/>
Transcription Factor Levels after Forward Programming of Human Pluripotent Stem Cells with GATA1, FLI1, and TAL1 Determine Megakaryocyte versus Erythroid Cell Fate Decision.  [electronic resource] 

 -  Stem cell reports  12 2018 
 - 1462-1478 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2213-6711 
<br/><br/><label>Standard No.: </label>10.1016/j.stemcr.2018.11.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Cell Differentiation--drug effects<br/>Cell Lineage--drug effects<br/>Cells, Cultured<br/>Cytokines--pharmacology<br/>Erythroid Cells--cytology<br/>Erythropoietin--pharmacology<br/>GATA1 Transcription Factor--metabolism<br/>Gene Silencing<br/>Humans<br/>Megakaryocytes--cytology<br/>Pluripotent Stem Cells--cytology<br/>Proto-Oncogene Protein c-fli-1--metabolism<br/>T-Cell Acute Lymphocytic Leukemia Protein 1--metabolism<br/>Thrombopoietin--pharmacology<br/>Transgenes